UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | G | H | J | M | P | R | S
Number of items: 9.

A

Almassy, R; Bowman, K; Calvert, AH; Curtin, NJ; Golding, BT; Hostomska, Z; Hostomsky, Z; (1998) 2-phenylbenzimidazole-4-carboxamides are potent inhibitors of the DNA repair enzyme poly(ADP-ribose)-polymerase (PARP). Annals of Oncology , 9 116 - ?.

G

Grant, S; Boyle, F; Calvert, AH; Curtin, NJ; Endicott, J; Golding, BT; Griffin, RJ; (1998) O-6-alkylguanines as selective inhibitors of cyclin dependent kinases. Annals of Oncology , 9 523 - ?.

H

Hughes, AN; Griffin, MJ; Calvert, AH; Johnston, A; Kerr, B; Lee, C; Newell, DR; (1998) Pharmacokinetic interactions in a phase I study of nolatrexed (AG337, THYMITAQ (TM)) and paclitaxel in patients with advanced solid tumours. Annals of Oncology , 9 463 - ?.

J

Jackman, AL; Mitchell, F; Lynn, S; Aherne, GW; Rees, C; Calvert, AH; Judson, IR; (1998) Evidence for the duration of the antifolate action of the thymidylate synthase (TS) inhibitor ZD9331 using plasma dUrd as a surrogate marker of enzyme inhibition. Annals of Oncology , 9 604O - ?.

M

Marshman, E; Calvert, AH; Newell, DR; Curtin, NJ; (1998) Dipyridamole selectively potentiates antipurine antifolates in human tumour cell lines but not normal tissue targets of dose-limiting toxicity. Annals of Oncology , 9 589 - ?.

Mitchell, F; Lynn, S; Rees, C; Judson, I; Calvert, AH; Ratain, M; Diab, S; (1998) Plasma 2 '-deoxyuridine (dUrd) as a surrogate marker of thymidylate synthase (TS) inhibition in patients in phase I clinical trials of the TS inhibitor ZD9331. Annals of Oncology , 9 614 - ?.

P

Plummer, R; Calvert, AH; Judson, I; Beale, P; Rees, C; Gokal, S; Highley, M; (1998) Phase I trial of ZD9331 given as a 30 minute infusion on days 1 and 8 with cycles repeated every 3 weeks. Annals of Oncology , 9 617 - ?.

R

Rees, C; Beale, P; Plummer, R; Highley, M; Calvert, AH; Judson, I; Smith, R; (1998) Phase I trial of ZD9331 given as a 30 minute infusion on days 1 and 8 with cycles repeated every 3 weeks. Annals of Oncology , 9 628P - ?.

S

Smith, PG; Newell, DR; Barnes, MJ; Calvert, AH; Curtin, NJ; (1998) Potentiation of the in vitro activity of the multi-targeted antifolate MTA (LY231514) by dipyridamole. Annals of Oncology , 9 588 - ?.

This list was generated on Sun Jul 24 03:16:27 2016 BST.